Global Digital Biomarkers Market is projected to witness a healthy growth rate of 35% from 2021 to 2026
Digital biomarkers are indexes that use data from digital platforms such as smartphones and wearable devices to objectively visualize the presence or absence of a disease, as well as changes caused by treatment. Digital biomarkers use advanced analytics and artificial intelligence (AI) algorithms to examine the data which would be impossible for humans to do alone. High Investments and Fundings to develop Novel Technologies to fuel the Market Demands It is predicted that digital biomarker is likely to be a vital tool for future diagnostic and treatment protocols for specific indications such as Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), cancer, among others . High growth of the digital biomarkers market has led to a number of investments and funding activities to accelerate research on digital biomarkers. Some of these are listed below: In May 2022, Imagene AI, an Israel based digital biomarker company, secured US$ 21.5 million funding that includes US$ 3 million in ...